DK0622356T3 - Indoloylguanidinderivater som inhibitorer af natrium-hydrogen-udbytningen - Google Patents

Indoloylguanidinderivater som inhibitorer af natrium-hydrogen-udbytningen

Info

Publication number
DK0622356T3
DK0622356T3 DK94303101T DK94303101T DK0622356T3 DK 0622356 T3 DK0622356 T3 DK 0622356T3 DK 94303101 T DK94303101 T DK 94303101T DK 94303101 T DK94303101 T DK 94303101T DK 0622356 T3 DK0622356 T3 DK 0622356T3
Authority
DK
Denmark
Prior art keywords
group
alkyl group
formula
substituted alkyl
hydrogen
Prior art date
Application number
DK94303101T
Other languages
Danish (da)
English (en)
Inventor
Atsuyuki Kojima
Masahumi Kitano
Akira Miyagishi
Tsuyoshi Noguchi
Hideki Yagi
Kazuhiro Nakano
Naohito Ohashi
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Application granted granted Critical
Publication of DK0622356T3 publication Critical patent/DK0622356T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94303101T 1993-04-28 1994-04-28 Indoloylguanidinderivater som inhibitorer af natrium-hydrogen-udbytningen DK0622356T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12508593 1993-04-28

Publications (1)

Publication Number Publication Date
DK0622356T3 true DK0622356T3 (da) 1998-10-26

Family

ID=14901466

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94303101T DK0622356T3 (da) 1993-04-28 1994-04-28 Indoloylguanidinderivater som inhibitorer af natrium-hydrogen-udbytningen

Country Status (10)

Country Link
EP (1) EP0622356B1 (fr)
KR (1) KR100295128B1 (fr)
CN (1) CN1051301C (fr)
AT (1) ATE167854T1 (fr)
CA (1) CA2121391A1 (fr)
DE (1) DE69411317T2 (fr)
DK (1) DK0622356T3 (fr)
ES (1) ES2117759T3 (fr)
GR (1) GR3027733T3 (fr)
TW (1) TW402600B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169107B1 (en) 1993-04-28 2001-01-02 Sumitomo Pharmaceutical Co., Ltd. Indoloylguanidine derivatives
US5852046A (en) * 1993-08-03 1998-12-22 Hoechst Aktiengesellschaft Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CA2160600A1 (fr) * 1994-10-18 1996-04-19 Masahumi Kitano Derives de l'indoloylguanidine
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
US6063806A (en) 1995-10-05 2000-05-16 Kyoto Pharmaceutical Industries, Ltd. Indolyl or indolinyl derivatives and medicinal use thereof as ACAT or lipid peroxidation inhibitors
DE19548708A1 (de) * 1995-12-23 1997-06-26 Merck Patent Gmbh Cyclische Sulfone
NZ314105A (en) 1996-02-02 1997-12-19 Sumitomo Pharma Guanidine derivative substituted with a substituted indole which is peri condensed with a heterocyclic ring
JPH09291076A (ja) * 1996-04-24 1997-11-11 Sumitomo Pharmaceut Co Ltd 置換グアニジン誘導体およびその製法
AU3255697A (en) * 1996-06-12 1998-01-07 F. Hoffmann-La Roche Ag A process for the manufacture of 1-(amino-alkyl)-indoles
CA2260499A1 (fr) * 1998-01-29 1999-07-29 Sumitomo Pharmaceuticals Company Limited Compositions pharmaceutiques pour le traitement de dommages ischemiques au cerveau
NZ504769A (en) 1998-02-27 2005-04-29 Pfizer Prod Inc N-[(substituted five-membered di- or triaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia
CA2370607A1 (fr) 1999-04-23 2000-11-02 Bristol-Myers Squibb Company Inhibiteurs d'echange sodium-protons a base de guandines d'acyle bicyclique et procede correspondant
AUPQ223999A0 (en) * 1999-08-16 1999-09-09 University Of Sydney, The Intracellular feedback controls in the diagnosis and treatment of human disease
EP1238971A4 (fr) * 1999-12-16 2003-02-26 Sumitomo Pharma Derives de guanidine substitues
FR2842525B1 (fr) * 2002-07-16 2005-05-13 Aventis Pharma Sa Derives de 3-guanidinocarbonyl-1-heteroaryl-indole, procede de preparation a titre de medicaments et compositions pharmaceutiques les renfermant
FR2842526B1 (fr) 2002-07-16 2007-07-13 Aventis Pharma Sa Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-indole, procede de preparation a titre de medicaments
WO2004007450A1 (fr) 2002-07-17 2004-01-22 Kyoto Pharmaceutical Industries, Ltd. Nouveau compose d'indoline et son utilisation therapeutique
FR2856062B1 (fr) * 2003-06-12 2005-11-11 Aventis Pharma Sa Derives 3-guanidinocarbonyl-heterocycle, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US7230007B2 (en) 2003-06-12 2007-06-12 Sanofi-Aventis Deutschland Gmbh Derivatives of 3-(Guanidinocarbonyl) heterocycle, methods of preparation and intermediates thereof, their use as medicaments, and pharmaceutical compositions therefrom
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
CA2573185A1 (fr) 2004-07-14 2006-02-23 Ptc Therapeutics, Inc. Procedes pour le traitement de l'hepatite c
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
MX2007000762A (es) 2004-07-22 2007-04-02 Ptc Therapeutics Inc Tienopiridinas para tratamientode hepatitis c.
JP5094394B2 (ja) 2005-04-20 2012-12-12 武田薬品工業株式会社 縮合複素環化合物
US8076348B2 (en) 2005-08-08 2011-12-13 Astellas Pharma Inc. Acylguanidine derivative or salt thereof
KR20080105092A (ko) 2006-02-20 2008-12-03 아스텔라스세이야쿠 가부시키가이샤 피롤 유도체 또는 그의 염
KR20080094962A (ko) * 2006-02-20 2008-10-27 아스텔라스세이야쿠 가부시키가이샤 아미드 유도체 또는 그의 염

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3304019A1 (de) * 1983-02-07 1984-08-09 Kali-Chemie Pharma Gmbh, 3000 Hannover 3-acyloxy-1-phenyl-2-aminocarbonylindol-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DE4127026A1 (de) * 1991-08-16 1993-02-18 Boehringer Ingelheim Kg Neue pyrazinderivate, ihre herstellung und verwendung
EP0639573A1 (fr) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Hétérocycles à cinq chaînons benzocondensés, procédé pour leur préparation, leur utilisation comme médicament et comme diagnostique aussi bien que les produits pharmaceutiques le contenant

Also Published As

Publication number Publication date
CA2121391A1 (fr) 1994-10-29
DE69411317D1 (de) 1998-08-06
ATE167854T1 (de) 1998-07-15
KR100295128B1 (ko) 2001-09-17
CN1106800A (zh) 1995-08-16
GR3027733T3 (en) 1998-11-30
ES2117759T3 (es) 1998-08-16
CN1051301C (zh) 2000-04-12
DE69411317T2 (de) 1999-02-18
EP0622356A1 (fr) 1994-11-02
EP0622356B1 (fr) 1998-07-01
TW402600B (en) 2000-08-21

Similar Documents

Publication Publication Date Title
DK0622356T3 (da) Indoloylguanidinderivater som inhibitorer af natrium-hydrogen-udbytningen
DK0606024T3 (da) Erythromycinderivater, en fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
DE69129611D1 (de) Sulfonamid-Derivate
NO972666D0 (no) Anilinderivater med nitrogenmonoksyd-synteseinhiberende aktivitet
NO942452D0 (no) Amid- og ureaderivater med antihyperkolesteremisk aktivitet, deres fremstilling og terapeutiske anvendelser
DK1113011T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
NO940245D0 (no) Quinolin eller quinazolinderivater, deres fremstilling og anvendelse
DE69329084T2 (de) Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
ES2061868T3 (es) Derivados ariloxi-, ariltio-, heteroariloxi-, heteroariltio-alquenilen-aminas.
GB1475586A (en) N-hydroxyamidine compounds
TH15125EX (th) อนุพันธ์อินดอลชนิดใหม่